OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,975 | -43.7% | 8,909 | -7.5% | 0.00% | – |
| Q2 2023 | $49,712 | +1.3% | 9,634 | +3.5% | 0.00% | – |
| Q1 2023 | $49,053 | +96.8% | 9,308 | +4.9% | 0.00% | – |
| Q4 2022 | $24,922 | -32.6% | 8,869 | 0.0% | 0.00% | – |
| Q3 2022 | $37,000 | 0.0% | 8,869 | -4.1% | 0.00% | – |
| Q2 2022 | $37,000 | -86.0% | 9,251 | -82.7% | 0.00% | – |
| Q1 2022 | $265,000 | -29.1% | 53,550 | 0.0% | 0.00% | – |
| Q4 2021 | $374,000 | +9.7% | 53,550 | +57.3% | 0.00% | – |
| Q3 2021 | $341,000 | +11.8% | 34,052 | +58.2% | 0.00% | – |
| Q2 2021 | $305,000 | -12.9% | 21,519 | +0.8% | 0.00% | – |
| Q1 2021 | $350,000 | -21.3% | 21,346 | -0.5% | 0.00% | – |
| Q4 2020 | $445,000 | +709.1% | 21,460 | +197.4% | 0.00% | – |
| Q3 2020 | $55,000 | -21.4% | 7,217 | -14.6% | 0.00% | – |
| Q2 2020 | $70,000 | +105.9% | 8,454 | +24.2% | 0.00% | – |
| Q1 2020 | $34,000 | +3.0% | 6,805 | -18.6% | 0.00% | – |
| Q4 2019 | $33,000 | +65.0% | 8,359 | +25.2% | 0.00% | – |
| Q3 2019 | $20,000 | -31.0% | 6,677 | 0.0% | 0.00% | – |
| Q2 2019 | $29,000 | +7.4% | 6,677 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +42.1% | 6,677 | +37.9% | 0.00% | – |
| Q4 2018 | $19,000 | -42.4% | 4,842 | 0.0% | 0.00% | – |
| Q3 2018 | $33,000 | 0.0% | 4,842 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | 0.0% | 4,842 | -4.7% | 0.00% | – |
| Q1 2018 | $33,000 | +22.2% | 5,083 | -14.9% | 0.00% | – |
| Q4 2017 | $27,000 | -28.9% | 5,975 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -30.9% | 5,975 | 0.0% | 0.00% | – |
| Q2 2017 | $55,000 | +96.4% | 5,975 | +96.2% | 0.00% | – |
| Q1 2017 | $28,000 | +12.0% | 3,045 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | – | 3,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |